The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction

Objectives: To present our experience, in Iraq, with sacral neuromodulation (SNM) in patients with refractory lower urinary tract dysfunction, with discussion of the factors that affect the response rate. Patients and methods: In this prospective, clinical, interventional study, 24 patients were eva...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Issam S. Al-Azzawi, Mohamed A.J. Al-Tamimi
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2018
Materias:	Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/24e70e87e63c46abac615e5d4e35639b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:24e70e87e63c46abac615e5d4e35639b
record_format	dspace
spelling	oai:doaj.org-article:24e70e87e63c46abac615e5d4e35639b2021-12-02T13:03:32ZThe first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction2090-598X10.1016/j.aju.2018.05.006https://doaj.org/article/24e70e87e63c46abac615e5d4e35639b2018-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2090598X1830072Xhttps://doaj.org/toc/2090-598XObjectives: To present our experience, in Iraq, with sacral neuromodulation (SNM) in patients with refractory lower urinary tract dysfunction, with discussion of the factors that affect the response rate. Patients and methods: In this prospective, clinical, interventional study, 24 patients were evaluated and treated by a team comprised of a Urologist and a Neurosurgeon with SNM over a 1.5-year period. The gender, age, pathology, and clinical presentation, were all studied and evaluated. Successful clinical response was defined as achieving a ≥50% improvement in voiding diary variables. Results: The mean age of those that responded to SNM was 28 years, with females responding better than males (10 of 14 vs four of 10). The SNM response rate according to presentation was six of 10 in those with overactive bladder/urge urinary incontinence, six of nine of those with urinary retention, and two of five in those with a mixed presentation. The response rate in idiopathic voiding dysfunctions was 11 of 13, whilst for neurogenic dysfunctions it was three of 11. Other benefits such as in bowel motion, erectile function, menstruation, power of lower limbs, and quality of life (QoL), were also recorded. The complications were reasonable for this minimally invasive procedure. Conclusion: SNM offers a good and durable solution for some functional bladder problems, if patients are well selected. There may also be additional extra-urinary benefits that contribute to improvements in QoL. SNM was well tolerated by our patients with an encouraging response rate, especially in psychologically stable patients with idiopathic dysfunctions. Keywords: Lower urinary tract dysfunction, Overactive bladder, Urge urinary incontinence, Urinary retention, NeuromodulationIssam S. Al-AzzawiMohamed A.J. Al-TamimiTaylor & Francis GrouparticleDiseases of the genitourinary system. UrologyRC870-923ENArab Journal of Urology, Vol 16, Iss 4, Pp 391-396 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the genitourinary system. Urology RC870-923
spellingShingle	Diseases of the genitourinary system. Urology RC870-923 Issam S. Al-Azzawi Mohamed A.J. Al-Tamimi The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
description	Objectives: To present our experience, in Iraq, with sacral neuromodulation (SNM) in patients with refractory lower urinary tract dysfunction, with discussion of the factors that affect the response rate. Patients and methods: In this prospective, clinical, interventional study, 24 patients were evaluated and treated by a team comprised of a Urologist and a Neurosurgeon with SNM over a 1.5-year period. The gender, age, pathology, and clinical presentation, were all studied and evaluated. Successful clinical response was defined as achieving a ≥50% improvement in voiding diary variables. Results: The mean age of those that responded to SNM was 28 years, with females responding better than males (10 of 14 vs four of 10). The SNM response rate according to presentation was six of 10 in those with overactive bladder/urge urinary incontinence, six of nine of those with urinary retention, and two of five in those with a mixed presentation. The response rate in idiopathic voiding dysfunctions was 11 of 13, whilst for neurogenic dysfunctions it was three of 11. Other benefits such as in bowel motion, erectile function, menstruation, power of lower limbs, and quality of life (QoL), were also recorded. The complications were reasonable for this minimally invasive procedure. Conclusion: SNM offers a good and durable solution for some functional bladder problems, if patients are well selected. There may also be additional extra-urinary benefits that contribute to improvements in QoL. SNM was well tolerated by our patients with an encouraging response rate, especially in psychologically stable patients with idiopathic dysfunctions. Keywords: Lower urinary tract dysfunction, Overactive bladder, Urge urinary incontinence, Urinary retention, Neuromodulation
format	article
author	Issam S. Al-Azzawi Mohamed A.J. Al-Tamimi
author_facet	Issam S. Al-Azzawi Mohamed A.J. Al-Tamimi
author_sort	Issam S. Al-Azzawi
title	The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
title_short	The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
title_full	The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
title_fullStr	The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
title_full_unstemmed	The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
title_sort	first iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction
publisher	Taylor & Francis Group
publishDate	2018
url	https://doaj.org/article/24e70e87e63c46abac615e5d4e35639b
work_keys_str_mv	AT issamsalazzawi thefirstiraqiexperienceinsacralneuromodulationforpatientswithlowerurinarytractdysfunction AT mohamedajaltamimi thefirstiraqiexperienceinsacralneuromodulationforpatientswithlowerurinarytractdysfunction AT issamsalazzawi firstiraqiexperienceinsacralneuromodulationforpatientswithlowerurinarytractdysfunction AT mohamedajaltamimi firstiraqiexperienceinsacralneuromodulationforpatientswithlowerurinarytractdysfunction
_version_	1718393494010068992

The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction

Ejemplares similares